GLP-1 Drugs Linked to Lower Epilepsy Risk in Diabetes Patients

(MedPage Today) — GLP-1 receptor agonists were tied to a lower risk of developing epilepsy in adults with type 2 diabetes, a large U.S. study showed.
Compared with DPP-4 inhibitors, GLP-1 receptor agonist use was associated with a 16% lower risk…

Source link : https://www.medpagetoday.com/neurology/seizures/118973

Author :

Publish date : 2025-12-11 22:15:00

Copyright for syndicated content belongs to the linked Source.

M	T	W	T	F	S	S
1	2	3	4	5	6	7
8	9	10	11	12	13	14
15	16	17	18	19	20	21
22	23	24	25	26	27	28
29	30	31

GLP-1 Drugs Linked to Lower Epilepsy Risk in Diabetes Patients

FDA Approves New Type of Antibiotic for Gonorrhea, First in Decades

Senators Urge More Localized Use of Donor Organs

Related Posts

Novel Oral Antibiotic Matches Standard Option for Urogenital Gonorrhea

New antibiotic could stave off drug-resistant gonorrhoea

First At-Home Device Approved for Depression

Senate Rejects Extension of Obamacare Subsidies

Senators Urge More Localized Use of Donor Organs

FDA Approves New Type of Antibiotic for Gonorrhea, First in Decades

Novel Oral Antibiotic Matches Standard Option for Urogenital Gonorrhea

New antibiotic could stave off drug-resistant gonorrhoea

First At-Home Device Approved for Depression

Senate Rejects Extension of Obamacare Subsidies

Senators Urge More Localized Use of Donor Organs

GLP-1 Drugs Linked to Lower Epilepsy Risk in Diabetes Patients

FDA Approves New Type of Antibiotic for Gonorrhea, First in Decades

RFK Jr.’s Former Group Urges FDA to Revoke COVID Vax Licenses

Categories

Archives